CIBC Private Wealth Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,961
Closed -$2.55M 3331
2024
Q1
$2.55M Buy
+7,961
New +$1.95M 0.01% 499
2023
Q3
Sell
-8,486
Closed -$2.42M 1135
2023
Q2
$2.42M Sell
8,486
-1,897
-18% -$527K 0.01% 469
2023
Q1
$2.25M Buy
+10,383
New +$2.02M 0.01% 499
2022
Q4
Sell
-10,613
Closed -$2.95M 960
2022
Q3
$2.95M Buy
+10,613
New +$2.7M 0.01% 429
2022
Q1
Sell
-8,864
Closed -$1.58M 1322
2021
Q4
$1.58M Sell
8,864
-8,633
-49% -$1.7M ﹤0.01% 557
2021
Q3
$3.6M Buy
+17,497
New +$3.44M 0.01% 423
2021
Q1
Sell
-9,603
Closed -$996K 1064
2020
Q4
$996K Buy
+9,603
New +$832K ﹤0.01% 638

Other funds holding SWAV

CIBC Private Wealth Group's SWAV Position: Q2 2024 in Review

CIBC Private Wealth Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 7,961 shares — an estimated $2.55M sold.

CIBC Private Wealth Group first reported a position in SWAV in Q4 2020 and held it in 7 quarters. The position peaked at $3.6M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • CIBC Private Wealth Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 7,961 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $2.55M.
  • CIBC Private Wealth Group first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • CIBC Private Wealth Group's Shockwave Medical, Inc. Common Stock position peaked at $3.6M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on CIBC Private Wealth Group's 13F filing for Q2 2024, filed 9 Aug 2024.